Literature DB >> 12480255

Roles of toll-like receptors in natural interferon-producing cells as sensors in immune surveillance.

Tomoki Ito1, Ryuichi Amakawa, Shirou Fukuhara.   

Abstract

Natural IFN-alpha/beta producing cells (IPCs) play a central role in innate immunity against microbial infections. In primary immune responses, toll-like receptors (TLRs), as major pattern-recognition receptors, are essential for IPCs as well as other antigen presenting cell (APC) subsets to recognize microbes. IPCs unequivocally express TLR7 and TLR9, and can respond to the respective ligand to produce IFN-alpha/beta and to rapidly differentiate into dendritic cells (DCs). Thereby, IPCs can not only activate innate immune system but also provoke T cell responses. Thus, IPCs link innate and adaptive immunity through TLR system. In addition, recent work has revealed the regulatory system of DC subsets in response to microbial invasion. In this context, by the different but complementary expression profile of TLRs, IPCs together with myeloid APC subsets constitute a rational system of immune surveillance that can cover a wide variety of pathogens and enlarge immune adjuvant effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12480255     DOI: 10.1016/s0198-8859(02)00750-4

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  11 in total

Review 1.  The plasmacytoid monocyte/interferon producing cells.

Authors:  Fabio Facchetti; William Vermi; David Mason; Marco Colonna
Journal:  Virchows Arch       Date:  2003-10-28       Impact factor: 4.064

2.  Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells.

Authors:  Hui Li; Jing Zhang; Ashok Kumar; Mei Zheng; Sally S Atherton; Fu-Shin X Yu
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

3.  CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo.

Authors:  Erika Schlaepfer; Annette Audigé; Barbara von Beust; Vania Manolova; Markus Weber; Helene Joller; Martin F Bachmann; Thomas M Kundig; Roberto F Speck
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Hepatitis C and innate immunity: recent advances.

Authors:  Gyongyi Szabo; Angela Dolganiuc
Journal:  Clin Liver Dis       Date:  2008-08       Impact factor: 6.126

5.  Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205.

Authors:  Madhav V Dhodapkar; Mario Sznol; Biwei Zhao; Ding Wang; Richard D Carvajal; Mary L Keohan; Ellen Chuang; Rachel E Sanborn; Jose Lutzky; John Powderly; Harriet Kluger; Sheela Tejwani; Jennifer Green; Venky Ramakrishna; Andrea Crocker; Laura Vitale; Michael Yellin; Thomas Davis; Tibor Keler
Journal:  Sci Transl Med       Date:  2014-04-16       Impact factor: 17.956

Review 6.  Toll-like receptors in antiviral innate immunity.

Authors:  Sandra N Lester; Kui Li
Journal:  J Mol Biol       Date:  2013-12-03       Impact factor: 5.469

Review 7.  Role of Type I and II Interferons in Colorectal Cancer and Melanoma.

Authors:  Simone Di Franco; Alice Turdo; Matilde Todaro; Giorgio Stassi
Journal:  Front Immunol       Date:  2017-07-26       Impact factor: 7.561

8.  Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor.

Authors:  Xiaoqin Wang; Weidong Xu; Subhra Mohapatra; Xiaoyuan Kong; Xu Li; Richard F Lockey; Shyam S Mohapatra
Journal:  Genet Vaccines Ther       Date:  2008-02-15

9.  Interactive transcriptome analysis of malaria patients and infecting Plasmodium falciparum.

Authors:  Junya Yamagishi; Anna Natori; Mohammed E M Tolba; Arthur E Mongan; Chihiro Sugimoto; Toshiaki Katayama; Shuichi Kawashima; Wojciech Makalowski; Ryuichiro Maeda; Yuki Eshita; Josef Tuda; Yutaka Suzuki
Journal:  Genome Res       Date:  2014-08-04       Impact factor: 9.043

Review 10.  Application potential of toll-like receptors in cancer immunotherapy: Systematic review.

Authors:  Ming Shi; Xi Chen; Kangruo Ye; Yuanfei Yao; Yu Li
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.